NYE FORBINDELSER OG LÆGEMIDDELSAMMENSÆTNINGER HERAF TIL BEHANDLING AF SYGDOMME

The present invention discloses compounds according to Formula I:wherein R1, R2, R3a, R3b, X, Y1, Y2, Y3, and Z are as defined herein.The present invention relates to compounds, methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, fo...

Full description

Saved in:
Bibliographic Details
Main Authors TIRERA, Amynata, ALVEY, Luke, Jonathan, DUTHION, Béranger, TEMAL-LAIB, Taoues, BONNATERRE, Florence, Marie-Emilie, DESROY, Nicolas, BUCHER, Denis, ANNOOT, Denis, Maurice, PEIXOTO, Christophe, JARY, Hélène, Marie
Format Patent
LanguageDanish
Published 31.01.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention discloses compounds according to Formula I:wherein R1, R2, R3a, R3b, X, Y1, Y2, Y3, and Z are as defined herein.The present invention relates to compounds, methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, for the prophylaxis and/or treatment of inflammatory diseases, autoinflammatory diseases, autoimmune diseases, proliferative diseases, fibrotic diseases, transplantation rejection, diseases involving impairment of cartilage turnover, congenital cartilage malformation, diseases involving impairment of bone turnover, diseases associated with hypersecretion of TNFα, interferons, IL-6, IL-12 and/or IL-23, respiratory diseases, endocrine and/or metabolic diseases, cardiovascular diseases, dermatological diseases, and/or abnormal angiogenesis associated diseases by administering the compound of the invention.
Bibliography:Application Number: DK18811769T